Arkolith/Insider Trading/AVTE/Form 4

Noyes Timothy P

CHIEF EXECUTIVE OFFICER, DirectorAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed May 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$216K
Net Open-Market Flow
-$216K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2024Option exercise(M)10K$2.14$21K10K
May 16, 2024Sell(S)1K$21.92$28K0
May 16, 2024Sell(S)9K$21.52$187K1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 16, 2024Option exercise(M)10K—$0343K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-013629) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML